High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 7563309.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We characterize an undescribed antigen on prostatic epithelial cells, which is recognized by anti-CD38. Normal (3 cases), benign hyperplastic (10) and carcinomatous (10) prostatic tissues were analyzed using immunohistochemistry, immuno-electron microscopy and the Western blot test. Comparison of prostatic and lymphatic CD38 antigen revealed identical bands at 45 kD. Electron microscopy demonstrated anti-CD38 reactivity on the cytoplasmic membrane and within the secretory vacuoles. Double labeling with anti-cytokeratin types 5/15 and 8/18 confirmed that basal and secretory normal prostatic epithelial cells express CD38. By contrast, a complete loss was found in malignant (52.8%), tumor-surrounding nonmalignant (16.3%) and benign prostatic hyperplasia derived glands (3.7%). CD38 is a novel prostatic antigen. Its role in intracellular calcium mobilization may contribute to smooth muscle cell contraction and/or sperm motility.
Medical subject headings
- Antigens, CD
- Antigens, Differentiation
- Gene Expression Regulation
- N-Glycosyl Hydrolases
- Prostate
- Prostatic Hyperplasia
- Prostatic Neoplasms